News
OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treated ...
IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback